Phase I safety and pharmacokinetic study of bevacizumab in Chinese patients with advanced cancer.
Jianyu Wu(Beijing Hospital), Gang Cheng, Xin Hu(Fudan University Shanghai Cancer Center), Xiaonan Wu(Xiamen University), Yunbo Zhao(University of Science and Technology of China), Yang Li(Beijing Tongren Hospital), Li Ding(Washington University in St. Louis), Bin Ai
PubMed
April 5, 2010
Cited by 26
Related Papers
The protective role of selenium on the toxicity of cisplatin-contained chemotherapy regimen in cancer patients
|Biological Trace Element Research|1997|122
Reproducibility of Subfoveal Choroidal Thickness Measurements with Enhanced Depth Imaging by Spectral-Domain Optical Coherence Tomography
|Investigative Ophthalmology & Visual Science|2012|121
Discovery of a potent SCAP degrader that ameliorates HFD-induced obesity, hyperlipidemia and insulin resistance via an autophagy-independent lysosomal pathway
|Autophagy|2020|99
Arginine methylation of HSP70 regulates retinoid acid-mediated <i>RARβ2</i> gene activation
|Proceedings of the National Academy of Sciences|2015|71